RxDoctor Payments Data

Vladimir Andries

Internal Medicine · Wawarsing, NYNPI 1265521165

Payments from drug & device makers

What this record shows

Almost everything reported here is food and beverage — 100.0% of the total across 97 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 18 manufacturers, the largest accounting for just 21.6% — the pattern of someone who eats at a lot of different presentations. Reporting peaked in 2022 at $618 and has fallen 58.2% since, to $258 in 2023.

$1,721in general payments, 2019–2025

Across 97 payments — averaging $17.74 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Merck$372
  • Novartis$288
  • CSL Behring$211
  • Lilly USA, LLC$152
  • AbbVie$138
  • Bayer$129
  • plus $430 from 12 others

What the payments were for

  • Food & beverage$1,721100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
22
23

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$1,721 in reported general payments places this provider in the 75th percentile of 9,771 internal medicine providers in New York.

See all internal medicine providers in New York →

Other internal medicine in Wawarsing

See the full list for New York →

Where these figures come from

Is this you, or does something look wrong? →